{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360574094923944704.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1001/jama.299.13.1561"}},{"identifier":{"@type":"URI","@value":"http://jamanetwork.com/journals/jama/fullarticle/181728"}}],"dc:title":[{"@value":"Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes"}],"dcterms:alternative":[{"@value":"The PERISCOPE Randomized Controlled Trial"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380574094923944707","@type":"Researcher","foaf:name":[{"@value":"Steven E. Nissen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944705","@type":"Researcher","foaf:name":[{"@value":"Stephen J. Nicholls"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944709","@type":"Researcher","foaf:name":[{"@value":"Kathy Wolski"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944704","@type":"Researcher","foaf:name":[{"@value":"Richard Nesto"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944716","@type":"Researcher","foaf:name":[{"@value":"Stuart Kupfer"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944715","@type":"Researcher","foaf:name":[{"@value":"Alfonso Perez"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944714","@type":"Researcher","foaf:name":[{"@value":"Horacio Jure"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944717","@type":"Researcher","foaf:name":[{"@value":"Robert De Larochellière"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944706","@type":"Researcher","foaf:name":[{"@value":"Cezar S. Staniloae"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944718","@type":"Researcher","foaf:name":[{"@value":"Kreton Mavromatis"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944711","@type":"Researcher","foaf:name":[{"@value":"Jacqueline Saw"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944710","@type":"Researcher","foaf:name":[{"@value":"Bo Hu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944712","@type":"Researcher","foaf:name":[{"@value":"A. Michael Lincoff"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944708","@type":"Researcher","foaf:name":[{"@value":"E. Murat Tuzcu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094923944713","@type":"Researcher","foaf:name":[{"@value":"for the PERISCOPE Investigators"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00987484"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00987484"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00987484"}],"prism:publicationName":[{"@value":"JAMA"}],"dc:publisher":[{"@value":"American Medical Association (AMA)"}],"prism:publicationDate":"2008-04-02","prism:volume":"299","prism:number":"13","prism:startingPage":"1561"},"reviewed":"false","url":[{"@id":"http://jamanetwork.com/journals/jama/fullarticle/181728"}],"createdAt":"2008-04-01","modifiedAt":"2016-12-15","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050282810834269440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Japanese Clinical Practice Guideline for Diabetes 2016"},{"@value":"The Japan Diabetes Society. Japanese Clinical Practice Guideline for Diabetes 2016"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231987914752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: Evaluation by intravascular ultrasound) extension trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232000256000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232257699072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232534436480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fish oil prevents excessive accumulation of subcutaneous fat caused by an adverse effect of pioglitazone treatment and positively changes adipocytes in KK mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233431426304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234565104128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235774726656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711692225024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of low-dose pioglitazone on glucose control, lipid profiles, renin-angiotensin-aldosterone system and natriuretic peptides in diabetic patients with coronary artery disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711764480512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711800580608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286991631063168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adiponectin, a unique adipocyte-derived factor beyond hormones"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165767698944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: Randomized controlled trial (PioRAGE)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181941325312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184436543232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone Decreases Asymmetric Dimethylarginine Levels in Patients with Impaired Glucose Tolerance or Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185727923840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187463317376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643256828928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Thiazolidinedione‐independent activation of peroxisome proliferator‐activated receptor γ is a potential target for diabetic macrovascular complications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657026091136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657187792128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849941584392576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204430700416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204430803072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anti-Atherosclerotic Potential of Dihydropyridine Calcium Channel Blockers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204430847488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Predictors of Atheroma Progression Despite Optimal Glycemic Control in Early-Stage Diabetic Patients with Coronary Artery Disease: Insight from the DIANA Study"},{"@value":"DIANA study investigators. Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: insight from the DIANA study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204432187776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Total Coronary Artery Plaque Burden Measured by Cardiac Computed Tomography is Associated with Metabolic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204433360256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-Term Effects of Pioglitazone on Carotid Atherosclerosis in Japanese Patients with Type 2 Diabetes without a Recent History of Macrovascular Morbidity"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204433774080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Retinoid X Receptor Heterodimer Variants and Cardiovascular Risk Factors"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205101935488","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Benefit of Adding Pioglitazone to Successful Statin Therapy in Nondiabetic Patients With Coronary Artery Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205104335744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Role of Peroxisome Proliferator-Activated Receptor-.GAMMA. in Atherosclerosis  - An Update -"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205105154944","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pioglitazone Reduces the Necrotic-Core Component in Coronary Plaque in Association With Enhanced Plasma Adiponectin in Patients With Type 2 Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205105684992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diabetes Mellitus Is a Major Negative Determinant of Coronary Plaque Regression During Statin Therapy in Patients With Acute Coronary Syndrome  - Serial Intravascular Ultrasound Observations From the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial) -"},{"@value":"Is What You See in Color Intravascular Ultrasound What You Want to Get?"},{"@value":"Regression-Resistant Plaque in Diabetic Patients"},{"@value":"Diabetes Mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679410041344","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Plaque Regression Determined by Intravascular Ultrasound Predicts Long-Term Outcomes of Patients with Acute Coronary Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679445627392","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Atherosclerotic Plaque Imaging for Evaluation of HDL Targeting Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679751746816","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Study of Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in Patients with Type 2 Diabetes Mellitus"},{"@language":"ja","@value":"2型糖尿病患者におけるジペプチジルペプチダーゼ-4阻害薬シタグリプチンの有効性および安全性に関する研究"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680082275712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Coronary Angioscopic Evaluation for Serial Changes of Luminal Appearance After Pharmacological and Catheter Interventions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680344131840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"抗動脈硬化治療薬としてのチアゾリジン誘導体"},{"@language":"en","@value":"S10-4. Antiarteriosclerotic Effect of Pioglitazone"}]},{"@id":"https://cir.nii.ac.jp/crid/1390578393608376320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390850247499524864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anti-inflammatory mechanisms of the vascular smooth muscle          PPARγ"}]},{"@id":"https://cir.nii.ac.jp/crid/1391131406293094272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1391412326427179392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1523951030061134848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GUIDELINE : Japanese Clinical Practice Guideline for Diabetes 2019"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1001/jama.299.13.1561"},{"@type":"CROSSREF","@value":"10.1038/ncomms7137_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1093/ehjci/jes033_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1111/jdi.12813_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-10-0380_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-09-0769_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.7793/jcoron.20.033_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00471-5_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1111/jdi.12810_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1177/1470320312452028_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1186/1475-2840-13-15_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1186/s12902-015-0045-y_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5582/ddt.2020.03073_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.atherosclerosis.2019.10.021_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.jcmg.2011.08.007_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-08-0699_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.jcmg.2013.09.004_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.atherosclerosis.2011.10.013_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.8953_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.3999/jscpt.41.59s_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2015.06.005_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.31948_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1089/rej.2013.1434_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1111/jdi.12567_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0048387_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.21089_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-0865_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00439-5_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej23-0160_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1111/j.2040-1124.2011.00182.x_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1007/s13340-018-0345-3_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1540/jsmr.57.1_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.atherosclerosis.2014.03.025_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.72.1193_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.6551_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.4663_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.39.309_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.12450_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.toxrep.2015.11.003_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2011.06.012_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1111/jdi.13306_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.atherosclerosis.2019.04.229_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1016/j.atherosclerosis.2011.07.113_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.5551/jat.no786_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-11-0060_references_DOI_UvQF4DGRpAdcDW8QFtqoEpxOWEF"}]}